United Kingdom IoT in Healthcare Market Summary
As per Transpire Insight Analysis the United Kingdom IoT in Healthcare Market size is estimated at USD 8.9 Billion in 2025 and is anticipated to reach USD 27.4 Billion by 2033, growing at a CAGR of 15.30% from 2026 to 2033.
The UK market for IoT in healthcare facilitates health data sharing and acquisition in real time, connecting patients, healthcare providers, and medical devices. Practically, this enables NHS and private healthcare providers to monitor patients remotely, trace medical assets, track chronic conditions, and prevent unnecessary hospital visits. Over the past 3-5 years, the market has transitioned from discrete connected devices towards integrated remote patient monitoring and data driven care models based on a larger adoption of digital health across the NHS.
A key catalyst was the COVID-19 pandemic, which caused the virtual consultation and remote patient monitoring movement during disruptions to routine face-to-face services.
This has boosted the value proposition for connected healthcare, enabling continuous data streams to potentially decrease hospital visits and enable clinical staff to optimize the allocation of their capacity. With interoperability and connected infrastructure reaching a critical point, providers are progressing IoT investments from proof-of-concept projects towards sustainable care paths, strengthening the prospects for revenue in the device, software, connectivity, and managed services markets.
United Kingdom IoT in Healthcare Market Size & Forecast:
- United Kingdom IoT in Healthcare Market Size 2025: USD 8.9 Billion
- Expected Market Value 2033: USD 27.4 Billion
- Forecast CAGR: 15.30%
- Leading region in 2025: England
- Fastest Growing region: Scotland
- Key Profile: Philips Healthcare, GE HealthCare, Siemens Healthineers, Medtronic, Abbott, Cisco, IBM, Oracle Health, Microsoft, Honeywell, Bosch Healthcare, Qualcomm, Telit Cinterion, Cerner, Dexcom.

Key Market Insights
- England accounts for an estimated 84% of the UK market in 2025, as NHS England provides a domestic digital-care infrastructure across the whole of the country.
- Scotland is the fastest growing area, with the market for connected-care set to boom in 2026-2031, powered by remote monitoring and digital health programmes.
- Medical devices hold the top spot as the connected monitoring hardware anchors IoT deployments, and maintains the most dominant 2025 position.
- The second largest component is system and software. This is gaining increasing strategic importance for vendors as device connectivity is linked to analytics, security, and clinical systems.
- System and software is forecast to be the fastest-growing segment through 2035, as healthcare providers invest heavily in interoperability, analytics, and scalable cloud infrastructure.
- Telemedicine leads in application, with worldwide research on IoT healthcare leading the charge in 2025 with the rise of connected consultations.
- The use of virtual wards is leading to a rapid expansion in patient monitoring, as connected devices become the dominant means of delivering continuous clinical monitoring at home.
- Hospitals and clinics will continue to be the primary end users, attracting large investment as NHS providers will roll out connected devices throughout clinical pathways.
- The fastest-growing end-user segment is contract research organizations (CROs) and this also signifies the increasing desire for interconnected data collection and distributed research methodology.
- At the same time Philips is building connected care capabilities and Microsoft is investing in NHS AI processes and Azure based healthcare data integration.
What are the Key Drivers, Restraints, and Opportunities in the United Kingdom IoT in Healthcare Market?
NHS drive towards home delivery of services is the largest growth driver NHS England is expanding virtual capacity across the UK and requires local trusts to Embedded, institutionalize and Scale these resources.Wireless connected oxygen, heart-rate, blood pressure and other devices feeding intoThese workflows, convertingIoTfrom equipment sales into Recurring software, hardware and data revenues. Adding a layer of intelligenceAI to convert Raw ReadingsInto actionable, informative events is what drives real value -Cera's predictive system was in use in more than two-thirds of NHS integrated care systems with2 million+ home visits delivered each month in Mar 2025.
The biggest barrier remains fragmented integration across the legacy clinical systems landscape -The new systems cannot all be bought simultaneouslyDue tolong procurement cycles, cybersecurity regulations, clinical validation requirements and interoperability testsThe hinder the rate of launch of hardware, increase implementation costsAnd affect cashflow for Vendors. The result is that even smart devices remain poorly utilized due to limited interoperability and poor clinical work flows to use the incoming data. From Transpire Insight’s research into regional procurement notices and project roadmaps, the risk associated with supply chain and delivery of devices remains the mainExecution Risk.
The second largest growth opportunity is TheAI supported connected Remote Monitoring as a linked capability for the NHS' virtual ward expansions and has committed£10 billion over three years for technology, digitisation and data integration initiatives. These are enhanced by London Region I, the regulatory sandbox program that offers a simplified path for the certification of new digital Health devices[will likely] open for in-market use by Summer 2026 enabling faster certification timelines and rollouts.
What Has the Impact of Artificial Intelligence Been on the United Kingdom IoT in Healthcare Market?
AI is shifting connected health away from solely collecting data towards using it for automated clinical support. In remote monitoring, algorithms can analyze continuously collected physiological signals, identify aberrant patterns and send an alert, prioritizing and directing the patient and the alerting physicians to respond. The sheer size possible can already be seen in the deployment of Cera with the NHS which analyzes more than 2 million home care visits per month and sends tens of thousands of risk alerts on this volume of data.
AI can forecast deterioration instead of solely recording an abnormality, enabling intervention at an earlier stage to minimize hospital admission.
Benefits can include operational efficiencies apart from patient monitoring: an NHS pilot of Microsoft 365 Copilot across 90 organizations reduced reported work time by an average of 43 minutes per staff member per day, the power in using AI is that it is converting collected data in to workflow savings thus further bolstering the business case for connected infra. However, the integration challenges are profound, as to realize the value in AI, both a good set of usable and inter-operable clinical data and extensive validation studies are required whereas legacy IT architecture presents a formidable cost of implementation and real world reliability issues.
Key Market Trends
- Expanded virtual wards by NHS England since 2023 to enable connected monitoring to move from fragmented pilot tests to routine, standardise at-home pathways.
- Reached two thirds of NHS ICs in 2025-Cera's AI monitoring platform facilitated rapid uptake of predictive at-home care.
- Deterioration monitoring enhanced by AI was widespread by March 2025-Cera processed over 2 million in-home care visits per month.
- Extended NHS AI collaboration in 2025-Microsoft demonstrated Dragon Copilot and partner tools aimed at enhancing clinical and administrative pathways.
- Facilitated faster uptake by the NHS with a funding of 10 Billion on technology digital and data system modernisation between 2026 and July 2026.
- Set up regulatory sandbox for real-world trials of AI-enabled medical devices in June 2026 (London Region I).
- Launched an AI-powered voice monitoring service at Barts Health in 2026 moving away from reliance on smart-phone applications for virtual-ward patients.
- Shift towards multimodal data for connected-care platforms (wearables readings, patient responses, clinical data and AI-derived risk assessments).
- Cyber security and interoperability rose up the procurement priority list of connected-care technologies, as they generated larger flows of clinical data through old infrastructures.
- Favored platforms offering IoT connectivity, cloud analytics, AI and integration over stand-alone connected-devices from 2025 on for healthcare technology investments.
United Kingdom IoT in Healthcare Market Segmentation
By Component :
Well-resourced, and on many counts, this is expected given the data the technologies can glean – linked to sensors, connected devices, data analytics software and the smart cloud platform for aggregation. Medical device providers have always had an in; the prevalence of connected monitors, connected devices, wearable sensors, smart infusion systems and connected diagnostic devices supports continuous monitoring for patients. An increasingly large number of hospitals, as well as home care providers, integrate connected devices into the overall software platform with enhanced monitoring and better medical decision making – on multiple devices.Because a lot of vital sign information data, in relation with sensors, helps for remotely monitoring.
This increases spending on cloud platforms, software, analytics platforms, to handle and transform vast amounts of data in a smart manner to improve clinical information and services on installment and support (Cybersecurity , technical support integration and many others ) which implies an increased demand to offer the complete package of technological solutions not standalone. The move beyond independent hardware-driven products into interconnected solutions offers a better opportunity for vendors in the medical market segment, a market that must focus on data, analytics as well as integration.
By Deployment :
Given the rise in need for scalable healthcare infrastructure for connected devices and patient data, the Cloud-Based deployment models will gain more prominence. Public Cloud systems, for instance, offer faster deployment timeframes and more flexible scalability. However, Private Cloud systems provide organizations more control and access to private healthcare data. Hybrid deployment models will also continue to maintain relevance as hospitals require scalability along with their on-premise environment. Edge Computing systems are also growing in importance, as it allows for local processing which is essential for applications where rapid response to clinical situations are crucial.
The On-Premise deployment models will continue to be dominant for hospitals that have existing IT infrastructure and in-house requirements for data management. Multi-Cloud models will reduce dependency on a single technology and also cater to the diverse system needs of healthcare networks. Decisions will also be driven by increased need for enhanced security, compatibility, data governance, operational costs and also the level of system performance. Technology vendors will be rewarded where they offer a suite of diverse deployment models that allow hospitals to replace legacy systems more gradually.
By Application :
Remote patient monitoring is still a leading area for connected devices because clinicians can access patient data out of the traditional healthcare establishment environment. Wide adoption is also influenced by the role that connected devices play in virtual wards, chronic disease management, and post discharge monitoring. Connected medical devices is one other leading application because connected devices can port readings into clinical systems, enabling quicker decision-making. Medication management is enabled by intelligent devices and reminders that make sure compliance is taken more seriously and reduce medical errors that relate to medication.
Clinical operations will leverage greater value through connected workflow and data collection and real time status of operations. Asset tracking can help hospitals find where equipment has gone so it can be efficiently used and there can be more than one device or purchasing of equipment unnecessary and hospital equipment downtime can be reduced. Telemedicine will be a close partner in remote monitoring because telemedicine will have a lot more patient data to draw from in the form of virtual appointments. Hospital management will leverage connected data when making their decisions on where patients can be housed, when to manage equipment and workflow throughout the hospital.

By End User :
Top end user spending market Hospitals: Hospitals are still the largest end user group as connected technologies are integrated in all workflows from patient monitoring to equipment usage, to managing clinical workflow, and to support operation. Clinics and Diagnostic Centers: The increasing affordability of connected diagnostic tools as well as remote monitoring will continue to drive an uptick in their adoption of these technologies. Home Healthcare: Connected home health applications will grow, with the shift from the hospital to home settings becoming feasible with a monitoring layer in the mix.
Pharma and Research:Connected devices will be used by Pharma companies and research institutes to facilitate clinical trials, collect data, or enable decentralized studies and trials.Government Healthcare Agencies: Will keep on funding their digital transformations as this area is crucial for implementing public healthcare service expansion plans and population health initiative. The hospital will again have the largest contribution to the end use segment whereas home healthcare will get strong consideration as a segment due to virtual ward and remote patient monitoring schemes across Great Britain.
By Connectivity :
A prevalent use of Wi-Fi in many hospitals, clinics and medical organizations is the support of connected medical devices and digital work streams in an existing network infrastructure. Bluetooth can be employed for wearable devices and personal/short-range patient monitoring devices while Cellular IoT applications are employed to provide coverage for mobile and home-based healthcare. LPWAN is considered for devices that require low power draw for long operating times and little data transmission needs. Zigbee and NFC will be prevalent in particular connected-device use cases demanding extremely short-range or identification capabilities.
Satellite IoT is and will continue to be a specific but niche choice for healthcare facilities situated outside the range of typical network coverage. Connectivity choice will have to be taken regarding power levels, volume of data needed, range and coverage, security needs and latency required. Cellular IoT and Wi-Fi are still central to extensive connected-healthcare deployments whereas low-power devices will likely be the future of an expanding range of wearable and remote monitoring solutions.
What are the Key Use Cases Driving the United Kingdom IoT in Healthcare Market?
Remote monitoring and care is the most common use case - deployed in hospitals,clinicsand homecare facilities. Monitoring using connected blood glucose,BPand O2 monitoring or wearable trackers enables clinicians to monitor a patient both inside and outside hospital settings. Used by NHS healthcare providers,connected remote monitoring helps manage long term conditions and support better management of patients outside hospital.NHS providers will use this technology to manage out of hospital conditions. The technology supports the effective deployment of clinicians and removes avoidable in-patient hospital admissions.
The second most popular NHS use case, ‘connected assets monitoring’ is expanding in hospitals and outpatients. To reduce lost or lost equipment, improving its use and supporting asset maintenance planning, organisations will increase the use of real-time equipment data from 20%. The third NHS and market ‘connected medication management’ which applies across clinics and homecare facilities, also appears popular.
The first emerging NHS or market use case is ‘connected clinical research’ where pharmaceutical manufacturers and research centres will expand use to manage non-centralised trials.A further significant but nascent use case identified by a sector respondent is ‘connected monitoring for predictive maintenance’.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 8.9 Billion |
|
Market size value in 2026 |
USD 10.1 Billion |
|
Revenue forecast in 2033 |
USD 27.4 Billion |
|
Growth rate |
CAGR of 15.30% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 - 2024 |
|
Forecast period |
2026 - 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Regional scope |
United Kingdom (England, Scotland, Wales, Northern Ireland) |
|
Key company profiled |
Philips Healthcare, GE HealthCare, Siemens Healthineers, Medtronic, Abbott, Cisco, IBM, Oracle Health, Microsoft, Honeywell, Bosch Healthcare, Qualcomm, Telit Cinterion, Cerner, Dexcom. |
|
Customization scope |
Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs. |
|
Report Segmentation |
By Component (Medical Devices, Software, Services, Sensors, Connectivity Solutions, Analytics Platforms, Cloud Platforms, Others); By Deployment (Cloud-Based, On-Premise, Hybrid, Private Cloud, Public Cloud, Edge Computing, Multi-Cloud, Others); By Application (Remote Patient Monitoring, Connected Medical Devices, Medication Management, Clinical Operations, Asset Tracking, Telemedicine, Hospital Management, Others); By End User (Hospitals, Clinics, Diagnostic Centers, Home Healthcare, Pharmaceutical Companies, Research Institutes, Government Healthcare, Others); By Connectivity (Wi-Fi, Bluetooth, Zigbee, Cellular IoT, LPWAN, NFC, Satellite IoT, Others). |
Which Regions are Driving the United Kingdom IoT in Healthcare Market Growth?
84% of UK IoT healthcare activity is centered in England due to the purchasing and digital infrastructure power of NHS England. National virtual ward schemes and investment into digital transformation initiatives generate a wider base for connected-care deployment compared to the rest of the UK. There are a range of NHS providers, technology developers and digital health companies involved in enabling device integration, data analysis and remote monitoring, with major purchasing budgets and growing virtual-care pathways set to cement England's market dominance up until 2033.
Scotland is a structurally contrasting market than England, with services centered around NHS Scotland and a focus on integrated services across different health domains. Consistent public sector funding combined with national digital health initiatives facilitate predictable and stable market growth that does not depend on large-scale hospital procurement initiatives. The community-based care model in Scotland has created a recurring market for connected-care and remote monitoring devices and software. The consistent nature of institutional procurement will keep Scotland an attractive market for healthcare technology suppliers.
Wales shows emerging growth, due to the ongoing introduction of digital transformation programs that are both enhancing the infrastructure for connected-care and contributing to a rise in the scope for technology enabled community care within NHS Wales. New investment in health digital services is contributing to improved data connectivity across NHS Wales and thereby providing further scope for home-based monitoring services. Small market volumes may generate specific market opportunities for niche, interoperable suppliers providing services focused on community-based remote monitoring and secure data management, and scale up within regional networks between 2026 and 2033 for entrants that focus on niche deployments.
Who are the Key Players in the United Kingdom IoT in Healthcare Market and How Do They Compete?
The UK healthcare IoT value chain remains somewhat fragmented between global tech companies, specialist digital health companies, and connected device vendors. The key issues that will always outweigh price for UK health buyers (in our view, though perhaps not to all participants) will include tech capabilities, interopability, security, and the ability to integrate with clinicians and existing systems. Large OEMs have been playing defense, trying to lock share with integrated systems and working closely with the NHS on these, whilst new entrants have looked at niche areas such as remote monitoring and predictive care.
For Microsoft they are focusing on how they can use cloud, data, and AI as well as workflow integration to deliver added value on top of connected devices, and build an ecosystem around their cloud offerings and data analytics tools by working with the NHS and partners.
Philips has the majority of its Connected Care focused on patient monitoring and clinical informatics, which is essentially ensuring they have end-to-end data visibility and workflows on their monitoring devices. GEHealthCare is well-known for their combined offering of connected imaging/monitoring and analytics. SIEMENS HEALTHCARE are strong on integrated diagnostics/imaging, combining IT and equipment, the ability to use data from these with other systems and supporting IT solutions has been an important pillar for them and they will look to leverage data across their whole footprint. Medtronic has perhaps the most specific focused area of offering and have primarily positioned themselves within connected medical devices and specifically remote patient monitoring especially for chronically ill patients.
Company List
- Philips Healthcare
- GE HealthCare
- Siemens Healthineers
- Medtronic
- Abbott
- Cisco
- IBM
- Oracle Health
- Microsoft
- Honeywell
- Bosch Healthcare
- Qualcomm
- Telit Cinterion
- Cerner
- Dexcom
Recent Development News
In March 2026, Mayden acquired Wellola, adding Portasana’s remote monitoring and patient-engagement capabilities to Mayden’s digital health portfolio. The deal strengthens integrated digital-care services for NHS providers by connecting remote monitoring, patient communication, and clinical systems.
Source: https://www.mayden.com/
In April 2025, Doccla partnered with NHS Greater Glasgow and Clyde to co-develop a virtual hospital with an initial 1,000 virtual beds. The partnership combines remote monitoring technology with clinical support, expanding connected home-based care across a health board serving more than 1.2 million people.
Source: https://www.healthcare-management.uk/
What Strategic Insights Define the Future of the United Kingdom IoT in Healthcare Market?
Within 5-7 years the UK IoT in Healthcare Market will see a move from individual connected devices to an interconnected AI enabled infrastructure in the form of connected health ecosystem. Inward push by NHS towards digital first pathways for patients, care in the home, unified record of patients and increasing use of connected monitoring will all lead to a decrease in hardware sales (upfront costs) and an increase in recurring revenue through software/analytics, connectivity and managed services. Perhaps the hidden danger will be the supplier dominance with leading cloud, data and platform vendors.
Relying on a small set of technologies increases lock-in/switching costs, makes procurement of new, innovative technology from less experienced companies difficult, and poses a potential threat with policy changes related to cost, security or cloud standards/access terms and conditions.
One exciting development that the UK market offers is the move to an “Integrated Single Patient record” and during 2026-28 the device players should consider how they will link their device data into this integrated system. Focus must remain on building into open-ended integrated platforms.
United Kingdom IoT in Healthcare Market Report Segmentation
By Component
- Medical Devices
- Software
- Services
- Sensors
- Connectivity Solutions
- Analytics Platforms
- Cloud Platforms
By Deployment
- Cloud-Based
- On-Premise
- Hybrid
- Private Cloud
- Public Cloud
- Edge Computing
- Multi-Cloud
By Application
- Remote Patient Monitoring
- Connected Medical Devices
- Medication Management
- Clinical Operations
- Asset Tracking
- Telemedicine
- Hospital Management
By End User
- Hospitals
- Clinics
- Diagnostic Centers
- Home Healthcare
- Pharmaceutical Companies
- Research Institutes
- Government Healthcare
By Connectivity
- Wi-Fi
- Bluetooth
- Zigbee
- Cellular IoT
- LPWAN
- NFC
- Satellite IoT
Frequently Asked Questions
Find quick answers to common questions.
The expected United Kingdom IoT in Healthcare Market size for the market will be USD 27.4 Billion in 2033.
Key segments for the United Kingdom IoT in Healthcare Market are By Component (Medical Devices, Software, Services, Sensors, Connectivity Solutions, Analytics Platforms, Cloud Platforms, Others); By Deployment (Cloud-Based, On-Premise, Hybrid, Private Cloud, Public Cloud, Edge Computing, Multi-Cloud, Others); By Application (Remote Patient Monitoring, Connected Medical Devices, Medication Management, Clinical Operations, Asset Tracking, Telemedicine, Hospital Management, Others); By End User (Hospitals, Clinics, Diagnostic Centers, Home Healthcare, Pharmaceutical Companies, Research Institutes, Government Healthcare, Others); By Connectivity (Wi-Fi, Bluetooth, Zigbee, Cellular IoT, LPWAN, NFC, Satellite IoT, Others).
Major United Kingdom IoT in Healthcare Market players are Philips Healthcare, GE HealthCare, Siemens Healthineers, Medtronic, Abbott, Cisco, IBM, Oracle Health, Microsoft, Honeywell, Bosch Healthcare, Qualcomm, Telit Cinterion, Cerner, Dexcom.
The United Kingdom IoT in Healthcare Market size is USD 8.9 Billion in 2025.
The United Kingdom IoT in Healthcare Market CAGR is 15.30% from 2026 to 2033.
- Philips Healthcare
- GE HealthCare
- Siemens Healthineers
- Medtronic
- Abbott
- Cisco
- IBM
- Oracle Health
- Microsoft
- Honeywell
- Bosch Healthcare
- Qualcomm
- Telit Cinterion
- Cerner
- Dexcom
Recently Published Reports
-
Apr 2026
AI in Diabetic Retinopathy Market
AI in Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Screening AI Systems, Diagnostic AI Systems, and Predictive AI Models), By Application Segment (Hospitals, Ophthalmology Clinics, Diagnostic Centers, and Research and Development), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 - 2031
-
Apr 2026
Psychometric Tests Market
Psychometric Tests Market Size, Share & Analysis Report By Type (Personality Tests, Ability/Aptitude Tests, Skill/Knowledge Tests, and Others), By Application (Talent Acquisition and Talent Management), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Apr 2026
Rare Biological Sample Collection Market
Rare Biological Sample Collection Market Size, Share & Analysis Report By Type (Isolation Kits & Reagent, Blood Collection Tubes, and Others), By Application (Oncology, Transcriptomics, Pharmacogenomics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Jul 2026
Diabetic Retinopathy Market
Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Proliferative Diabetic Retinopathy, and Diabetic Macular Edema (DME)), By Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
Our Clients
.jpg)






